LeadIQ logo
Learn more at LeadIQ.com

Insights

Stem Cell Therapy Focus Xintela specializes in stem cell therapy and targeted cancer therapy using their patented integrin marker technology. This focus presents a significant sales opportunity in the regenerative medicine market.

Expansion through Partnerships Recent partnerships with companies like Carnegie Investment Bank AB showcase Xintela's commitment to strategic growth. Leveraging these collaborations can lead to new business opportunities and market expansions.

Key Personnel Addition The appointment of Lucienne Vonk as Chief Scientific Officer brings valuable expertise to Xintela's leadership team. Leveraging Vonk's knowledge can enhance credibility and attract new clients in the biotech industry.

Innovative Cancer Therapy Development of therapeutic antibodies targeting integrin α10β1 for triple-negative breast cancer and glioblastoma treatment positions Xintela as a key player in innovative cancer therapies. This breakthrough technology can attract collaborations and partnerships in the oncology field.

Financial Stability and Growth Potential With a revenue range of $0 - 10M and funding of $940K, Xintela demonstrates financial stability and growth potential. This financial health presents an opportunity for investors and stakeholders looking to partner with a promising biotech company.

Xintela AB Tech Stack

Xintela AB uses 2 technology products and services including jQuery, Adobe Fonts, and more. Explore Xintela AB's tech stack below.

  • jQuery
    Javascript Libraries
  • Adobe Fonts
    Web Fonts

Xintela AB's Email Address Formats

Xintela AB uses at least 1 format(s):
Xintela AB Email FormatsExamplePercentage
First.Last@xintela.seJohn.Doe@xintela.se
37%
First@xintela.seJohn@xintela.se
19%
Last@xintela.seDoe@xintela.se
7%
First.Last@xintela.seJohn.Doe@xintela.se
37%

Frequently Asked Questions

Where is Xintela AB's headquarters located?

Minus sign iconPlus sign iconXintela AB's main headquarters is located at Scheelevägen Lund, Skåne 22381 SE. The company has employees across 1 continents, including Europe.

What is Xintela AB's phone number?

Minus sign iconPlus sign icon You can contact Xintela AB's main corporate office by phone at
+46-70-329-1****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Xintela AB's official website and social media links?

Minus sign iconPlus sign iconXintela AB's official website is xintela.se and has social profiles on LinkedIn.

How much revenue does Xintela AB generate?

Minus sign iconPlus sign icon As of November 2024, Xintela AB's annual revenue reached $3.8M.

What is Xintela AB's SIC code NAICS code?

Minus sign iconPlus sign iconXintela AB's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Xintela AB have currently?

Minus sign iconPlus sign iconAs of November 2024, Xintela AB has approximately 19 employees across 1 continents, including Europe. Key team members include Chief Scientific Officer: L. V.Head Of Manufacturing: C. R.Head Of Manufacturing: C. R.. Explore Xintela AB's employee directory with LeadIQ.

What industry does Xintela AB belong to?

Minus sign iconPlus sign iconXintela AB operates in the Biotechnology Research industry.

What technology does Xintela AB use?

Minus sign iconPlus sign iconXintela AB's tech stack includes jQueryAdobe Fonts.

What is Xintela AB's email format?

Minus sign iconPlus sign iconXintela AB's email format typically follows the pattern of . Find more Xintela AB email formats with LeadIQ.

How much funding has Xintela AB raised to date?

Minus sign iconPlus sign icon As of November 2024, Xintela AB has raised $940K in funding. The last funding round occurred on Oct 22, 2013 for $940K.

When was Xintela AB founded?

Minus sign iconPlus sign iconXintela AB was founded in 2009.
Xintela AB

Xintela AB

Biotechnology ResearchSkåne, Sweden11-50 Employees

Xintela develops medical products in stem cell therapy and targeted cancer therapy based on the Company's cell surface marker integrin α10β1 which is found on mesenchymal stem cells and on certain aggressive cancer cells. The stem cell marker is used to select and quality-assure the patent-protected stem cell product XSTEM®, which is in clinical development for treatment of knee osteoarthritis and difficult-to-heal leg ulcers. The company produces XSTEM for the clinical studies in its GMP-approved manufacturing facility. In cancer therapy, which is run by the wholly owned subsidiary Targinta AB, therapeutic antibodies, targeting integrin α10β1 (First-in-Class) are being developed for the treatment of triple-negative breast cancer and the brain tumor glioblastoma.

Section iconCompany Overview

Headquarters
Scheelevägen Lund, Skåne 22381 SE
Phone number
+46-70-329-1****
Website
xintela.se
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2009
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $940K

    Xintela AB has raised a total of $940K of funding over 1 rounds. Their latest funding round was raised on Oct 22, 2013 in the amount of $940K.

  • $10M

    Xintela AB's revenue is in the range of $10M

Section iconFunding & Financials

  • $940K

    Xintela AB has raised a total of $940K of funding over 1 rounds. Their latest funding round was raised on Oct 22, 2013 in the amount of $940K.

  • $10M

    Xintela AB's revenue is in the range of $10M

Company Leadership

  • Stylized image of a person
    L. V.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. R.
    Head Of Manufacturing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. R.
    Head Of Manufacturing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. S.
    Head Of Quality Control
    Phone icon
    Mobile Phone
  • Stylized image of a person
    P. B.
    Head Technical Operations
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    C. R.
    Head Of Manufacturing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. R.
    Head Of Manufacturing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. S.
    Head Of Quality Control
    Phone icon
    Mobile Phone
  • Stylized image of a person
    P. B.
    Head Technical Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. W.
    Director Clinical Development
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.